在现象学基础上发现了新型正胆激酶抑制剂的发现
Ludwig G Bauer1,2, Jennifer A Ward1,2, Laura Díaz-Sáez1,2
1Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
希斯甲基转移酶抑制剂意外地向胆激酶α (CHKA),这是细胞代谢的关键调节剂. 这一发现为开发用于癌症和免疫研究的CHKA抑制剂提供了新的途径.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 胆酶α (CHKA) 对于细胞代谢,癌症和免疫调节至关重要.
- 为研究开发有效的CHKA抑制剂一直是个挑战.
- 目前对G9a/GLP抑制剂的研究显示了细胞测定中的差异.
研究的目的:
- 为了确定新基甲基转移酶抑制剂的新目标.
- 研究CHKA在免疫信号传递中的作用.
- 开发用于CHKA研究的化学工具.
主要方法:
- 综合现象查,以识别非目标物种.
- 化学蛋白质组,生物化学,细胞和代谢分析.
- 用CHKA确定抑制剂的共同晶体结构.
主要成果:
- 鉴定出CHKA是一种非向的氨基基纳素组合素甲基转移酶抑制剂 (UNC0638,UNC0737).
- 抑制CHKA会影响人类细胞中的IgG分泌和B细胞成熟.
- 揭示了UNC0638和UNC0737与CHKA的意外结合方式.
结论:
- 阿米诺基纳林是CHKA的直接抑制剂,这解释了之前的测定差异.
- CHKA在免疫信号传递中发挥着重要作用,特别是在B细胞功能中.
- UNC0638和UNC0737是开发选择性CHKA化学探针的有价值的起点.
更多相关视频
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
07:18A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
相关概念视频
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Drug Discovery: Overview
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
